Aspartate

Urine aspartate has been associated with kidney function and studied in children with autism. These findings haven't established a reliable way to interpret an individual result for either purpose. Its use as a standalone marker of kidney health, brain function, or healthy aging remains exploratory.

What You're Measuring

Your body makes aspartate and uses it in protein production, nitrogen disposal, and energy metabolism. The kidneys filter circulating amino acids and recover much of what they filter. Aspartate in urine therefore depends on both its availability in the body and its handling by the kidneys; a urine result doesn't measure its concentration or activity in the brain.

This test uses LC-MS to measure aspartate in urine. The method separates compounds in the sample and uses characteristic mass signals to identify and quantify them. Results are reported in mcg/g. This means micrograms per gram, but the catalog doesn't identify what the gram refers to. Creatinine adjustment must be confirmed on the laboratory report.

Clinical Uses and Kidney Research

Urine amino acid panels have an established role in evaluating suspected inherited disorders of amino acid metabolism or transport. One rare inherited transport disorder causes excessive loss of both aspartate and glutamate in urine. That finding comes from specialist biochemical and genetic investigations. An isolated aspartate result cannot establish the diagnosis.

Research into common kidney disease asks a different question: whether urine aspartate adds useful information about filtration or damage. The evidence so far includes these observational comparisons.

Both studies used LC-MS-based methods, but their preparation and reporting procedures don't establish an interchangeable scale with this mcg/g result. They also don't establish whether raising or lowering urine aspartate would improve kidney health.

Autism Research in Children

Urine studies have reported opposite findings. A 2019 study found lower aspartate in autistic children, while a 2024 study of 75 children found higher levels. The earlier study treated urine with strong acid and heat before analysis, which changes the amino acid pool being measured. The later study reported concentrations per volume without correcting for urine creatinine. These differences limit direct comparison with each other and with this assay.

Other autism research used different specimens. A study of 708 children identified patterns in plasma, while a study of 344 autistic children linked higher aspartic acid in dried whole-blood spots with greater symptom severity. Neither finding establishes a corresponding urine pattern. The conflicting urine results remain unresolved, and urine aspartate has no validated role in diagnosing autism, excluding it, or grading its severity.

What Blood Studies Add

In 1,799 American Indian adults followed for about 20 years, higher plasma aspartic acid was associated with lower subsequent coronary heart disease risk. A separate stomach cancer study found an association with higher plasma L-aspartic acid and used genetic analyses that supported a possible causal contribution. Those genetic analyses depend on assumptions about how the inherited variants affect disease.

Both findings concern plasma. They don't establish a urine target or show that changing your urine result changes heart or cancer risk.

When Results Can Be Misleading

• Urine concentration and reporting: hydration affects urine concentrations. If the laboratory divides the result by urine creatinine, variation in creatinine excretion can also influence the ratio. The catalog's unit alone doesn't confirm that this adjustment is used.
• Meals, timing, and activity: studies of broad urine chemical profiles show variation with meals, time of day, and exercise. They don't provide a validated correction for this particular aspartate assay.
• Analytical interference: other urine components can weaken the mass-spectrometry signal. Incomplete separation of compounds can also affect identification. Calibration and suitable internal standards help control these problems.
• Sample preparation and storage: different preparation procedures can measure different amino acid pools. Handling outside a laboratory's validated conditions can also affect results; there is no universal storage rule for every LC-MS assay.

What Serial Results Can Show

A study of first-morning urine from 12 healthy adults documented natural variation in amino acid results. That helps explain why two measurements can differ, but it doesn't establish a change that predicts better or worse health for this test. The preventive value of collecting a personal baseline has not been established.